1. MicroRNA 320, an Anti-Oncogene Target miRNA for Cancer Therapy
   Yuanyuan Liang et al, 2021, Biomedicines CrossRef
2. Approaches Toward Targeting Matrix Metalloproteases for Prognosis and Therapies in Gynecological Cancer: MicroRNAs as a Molecular Driver
   Anuradha Pandit et al, 2022, Frontiers in Oncology CrossRef
3. Downregulation of PRMT5 by AMI-1 enhances therapeutic efficacy of compound kushen injection in lung carcinoma in vitro and in vivo
   Ruiying Yang et al, 2023, Molecular and Cellular Biochemistry CrossRef
4. Analysis of m7G methylation modification patterns and pulmonary vascular immune microenvironment in pulmonary arterial hypertension
   Desheng Wang et al, 2022, Frontiers in Immunology CrossRef
5. Curcuminoids as Modulators of EMT in Invasive Cancers: A Review of Molecular Targets With the Contribution of Malignant Mesothelioma Studies
   Daniel L. Pouliquen et al, 2022, Frontiers in Pharmacology CrossRef
6. The Role of miRNAs 340-5p, 92a-3p, and 381-3p in Patients with Endometriosis: A Plasma and Mesenchymal Stem-Like Cell Study
   Afshin Bahramy et al, 2021, BioMed Research International CrossRef
7. miR-340-5p mediates the therapeutic effect of mesenchymal stem cells on corneal neovascularization
   Jian Pan et al, 2022, Graefe's Archive for Clinical and Experimental Ophthalmology CrossRef
8. Non-Coding RNAs as Prognostic Markers for Endometrial Cancer
   Roberto Piergentili et al, 2021, International Journal of Molecular Sciences CrossRef
9. The Interplay of Tumor Stroma and Translational Factors in Endometrial Cancer
   Monika Sobočan et al, 2020, Cancers CrossRef
10. Eukaryotic initiating factor eIF4E is targeted by EBV-encoded miR-BART11-3p and regulates cell cycle and apoptosis in EBV-associated gastric carcinoma
    Hanqing Wang et al, 2021, Virus Genes CrossRef
11. Canonical TGFβ Signaling and Its Contribution to Endometrial Cancer Development and Progression—Underestimated Target of Anticancer Strategies
    Piotr K. Zakrzewski, 2021, Journal of Clinical Medicine CrossRef
12. Detection of Increased Expression of Claudin-1 in Triple-Negative Breast Cancer: Analysis and Clinical-Pathological Correlation
    Abderrahman Ouban et al, 2023, Cureus CrossRef
13. MicroRNA as Epigenetic Modifiers in Endometrial Cancer: A Systematic Review
    Amélia Favier et al, 2021, Cancers CrossRef
14. Is Tissue Still the Issue? The Promise of Liquid Biopsy in Uveal Melanoma
    Daniël P. de Bruyn et al, 2022, Biomedicines CrossRef
15. The Role of miRNAs in the Regulation of Endometrial Cancer Invasiveness and Metastasis—A Systematic Review
    Klaudia Klicka et al, 2021, Cancers CrossRef
16. The interplay of sex steroid hormones and microRNAs in endometrial cancer: current understanding and future directions
    Lovlesh Thakur et al, 2023, Frontiers in Endocrinology CrossRef